Trabecular micro-bypass implant (iStent®) in a case of bilateral acute depigmentation of the iris
2022

Using iStent® for Eye Pressure Control in Iris Depigmentation

Sample size: 1 publication Evidence: low

Author Information

Author(s): Heloisa Andrade Maestrini, Angela Andrade Maestrini, Sarah Pereira de Freitas Cenachi, José Aloisio Massote, Amanda Batista Lopes, Thatiana Almeida Pereira Fernandes

Primary Institution: Oculare Hospital de Oftalmologia, Belo Horizonte, MG, Brazil

Hypothesis

Can iStent® effectively control intraocular pressure in cases of bilateral acute depigmentation of the iris?

Conclusion

The iStent® was found to be safe and effective in controlling intraocular pressure after the resolution of acute iris depigmentation.

Supporting Evidence

  • The patient had a history of bilateral acute depigmentation of the iris.
  • She experienced ocular hypertension and was treated with various medications.
  • After surgery, her intraocular pressure was significantly reduced without medication.

Takeaway

A woman with eye problems got a special implant that helped lower her eye pressure after her condition got better.

Methodology

The patient was treated with various medications and underwent combined cataract-iStent® surgery.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

One 62-year-old woman.

Digital Object Identifier (DOI)

10.5935/0004-2749.2021-0239

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication